{"artifact_id":"wiki-clinical-trials-gsk4527226-al101-nct06079190","artifact_type":"wiki_page","title":"GSK4527226 (AL101) for Early Alzheimer's Disease (NCT06079190)","quality_score":0.5,"is_latest":1,"version_number":1,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"related":87,"see_also":412},"total_incoming":499,"outgoing_by_type":{"related":80,"see_also":412,"mentions":26},"total_outgoing":518,"quality_trajectory":[],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":1017,"is_well_supported":false,"is_controversial":false,"is_foundational":false}